Further investigation is required to gain a deeper understanding of the infiltrating immune populations in CHS that express and utilize CD38, their interactions with tumor cells, and the potential targeting of these cells and molecules for the effective elimination of CHS. This evidence concerns the gene CD38 and neoplasm.